Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gender issues in multiple sclerosis.

Robert N Schwendimann1, Nadejda Alekseeva

  • 1Department of Neurology, Louisiana State University, Health Sciences Center, Shreveport Louisiana 71103, USA.

International Review of Neurobiology
|May 29, 2007
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) affects women more than men and has different clinical courses. Sex hormones may explain these differences and offer new treatment avenues for MS, including sexual dysfunction.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic and Toxic Myelopathies.

Continuum (Minneapolis, Minn.)·2018
Same author

Liver Disease and Neurology.

Continuum (Minneapolis, Minn.)·2017
Same author

Traumatic Brain Injury and Behavior: A Practical Approach.

Neurologic clinics·2015
Same author

Toxic-metabolic, nutritional, and medicinal-induced disorders of cerebellum.

Neurologic clinics·2014
Same author

Metabolic, nutritional, and toxic myelopathies.

Neurologic clinics·2012
Same author

Multiple sclerosis and pain.

Neurological research·2012
Same journal

Glutamate-Glutamine metabolism and transport, implications in Parkinson's disease.

International review of neurobiology·2026
Same journal

Redox bioenergetics of neuronal senescence in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Neurovascular coupling and energy substrate delivery in Alzheimer's disease.

International review of neurobiology·2026
Same journal

From metals to mitochondria: Linking trace elements to energy crisis in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Invisible threats of microplastics induced toxicity: Oxidative and inflammatory pathways in the CNS and retina.

International review of neurobiology·2026
Same journal

Starved synapses: Gut microbiome dysbiosis and its role in Alzheimer's glucose impairment.

International review of neurobiology·2026
See all related articles

Area of Science:

  • Neuroimmunology
  • Endocrinology
  • Epidemiology

Background:

  • Multiple sclerosis (MS) exhibits significant gender-based variations in prevalence and clinical presentation.
  • Women are disproportionately affected by MS, often experiencing a distinct disease course compared to men.
  • MS symptoms may ameliorate during pregnancy, suggesting hormonal influences.

Purpose of the Study:

  • To explore the biological underpinnings of gender disparities in multiple sclerosis.
  • To investigate the role of sex hormones in modulating MS pathology and clinical outcomes.
  • To identify potential therapeutic targets based on hormonal influences for MS treatment.

Main Methods:

  • Review of existing literature on sex hormones, cytokines, and multiple sclerosis.
  • Analysis of epidemiological data regarding gender prevalence in MS.
  • Discussion of hormonal effects on immune responses relevant to MS.

Main Results:

  • Sex hormones are implicated as key factors influencing the differing prevalence and course of MS between genders.
  • Hormonal modulation of cytokines and other immune factors may contribute to MS pathogenesis.
  • Pregnancy-associated symptom relief in MS suggests a protective role of certain hormonal states.

Conclusions:

  • Understanding sex hormone influences offers promising avenues for novel MS therapeutic strategies.
  • Hormonal insights are crucial for managing MS in women of childbearing age, including the use of disease-modifying agents.
  • Targeting hormonal pathways may also address MS-related sexual dysfunction.